APA (7th ed.) Citation

MB, D., YA, W., NP, C., VK, K., Z, E., SJ, G., . . . BP, B. (2026). Ampyrone is a direct agonist of human tyrosinase and a potential therapeutic for hypopigmentation disorders. JCI insight. https://doi.org/10.1172/jci.insight.202947

Chicago Style (17th ed.) Citation

MB, Dolinska, et al. "Ampyrone Is a Direct Agonist of Human Tyrosinase and a Potential Therapeutic for Hypopigmentation Disorders." JCI Insight 2026. https://doi.org/10.1172/jci.insight.202947.

MLA (9th ed.) Citation

MB, Dolinska, et al. "Ampyrone Is a Direct Agonist of Human Tyrosinase and a Potential Therapeutic for Hypopigmentation Disorders." JCI Insight, 2026, https://doi.org/10.1172/jci.insight.202947.